461 related articles for article (PubMed ID: 25988728)
1. Nitric oxide releasing hydrogel enhances the therapeutic efficacy of mesenchymal stem cells for myocardial infarction.
Yao X; Liu Y; Gao J; Yang L; Mao D; Stefanitsch C; Li Y; Zhang J; Ou L; Kong D; Zhao Q; Li Z
Biomaterials; 2015 Aug; 60():130-40. PubMed ID: 25988728
[TBL] [Abstract][Full Text] [Related]
2. Selective inhibition of inositol hexakisphosphate kinases (IP6Ks) enhances mesenchymal stem cell engraftment and improves therapeutic efficacy for myocardial infarction.
Zhang Z; Liang D; Gao X; Zhao C; Qin X; Xu Y; Su T; Sun D; Li W; Wang H; Liu B; Cao F
Basic Res Cardiol; 2014 Jul; 109(4):417. PubMed ID: 24847908
[TBL] [Abstract][Full Text] [Related]
3. Mesenchymal stem cells over-expressing SDF-1 promote angiogenesis and improve heart function in experimental myocardial infarction in rats.
Tang J; Wang J; Yang J; Kong X; Zheng F; Guo L; Zhang L; Huang Y
Eur J Cardiothorac Surg; 2009 Oct; 36(4):644-50. PubMed ID: 19524448
[TBL] [Abstract][Full Text] [Related]
4. Chitosan/silk fibroin modified nanofibrous patches with mesenchymal stem cells prevent heart remodeling post-myocardial infarction in rats.
Chen J; Zhan Y; Wang Y; Han D; Tao B; Luo Z; Ma S; Wang Q; Li X; Fan L; Li C; Deng H; Cao F
Acta Biomater; 2018 Oct; 80():154-168. PubMed ID: 30218777
[TBL] [Abstract][Full Text] [Related]
5. Rosuvastatin enhances the therapeutic efficacy of adipose-derived mesenchymal stem cells for myocardial infarction via PI3K/Akt and MEK/ERK pathways.
Zhang Z; Li S; Cui M; Gao X; Sun D; Qin X; Narsinh K; Li C; Jia H; Li C; Han Y; Wang H; Cao F
Basic Res Cardiol; 2013 Mar; 108(2):333. PubMed ID: 23386286
[TBL] [Abstract][Full Text] [Related]
6. Transplantation of adipose tissue mesenchymal cells conjugated with VEGF-releasing microcarriers promotes repair in murine myocardial infarction.
Madonna R; Petrov L; Teberino MA; Manzoli L; Karam JP; Renna FV; Ferdinandy P; Montero-Menei CN; Ylä-Herttuala S; De Caterina R
Cardiovasc Res; 2015 Oct; 108(1):39-49. PubMed ID: 26187727
[TBL] [Abstract][Full Text] [Related]
7. Thioredoxin-1 (Trx1) engineered mesenchymal stem cell therapy increased pro-angiogenic factors, reduced fibrosis and improved heart function in the infarcted rat myocardium.
Suresh SC; Selvaraju V; Thirunavukkarasu M; Goldman JW; Husain A; Alexander Palesty J; Sanchez JA; McFadden DW; Maulik N
Int J Cardiol; 2015 Dec; 201():517-28. PubMed ID: 26322599
[TBL] [Abstract][Full Text] [Related]
8. C-Kit Positive Cardiac Stem Cells and Bone Marrow-Derived Mesenchymal Stem Cells Synergistically Enhance Angiogenesis and Improve Cardiac Function After Myocardial Infarction in a Paracrine Manner.
Bao L; Meng Q; Li Y; Deng S; Yu Z; Liu Z; Zhang L; Fan H
J Card Fail; 2017 May; 23(5):403-415. PubMed ID: 28284757
[TBL] [Abstract][Full Text] [Related]
9. IGF-1C domain-modified hydrogel enhances therapeutic potential of mesenchymal stem cells for hindlimb ischemia.
Zhao N; Yue Z; Cui J; Yao Y; Song X; Cui B; Qi X; Han Z; Han ZC; Guo Z; He ZX; Li Z
Stem Cell Res Ther; 2019 Apr; 10(1):129. PubMed ID: 31036073
[TBL] [Abstract][Full Text] [Related]
10. Pretreatment of mesenchymal stem cells with angiotensin II enhances paracrine effects, angiogenesis, gap junction formation and therapeutic efficacy for myocardial infarction.
Liu C; Fan Y; Zhou L; Zhu HY; Song YC; Hu L; Wang Y; Li QP
Int J Cardiol; 2015 Jun; 188():22-32. PubMed ID: 25880576
[TBL] [Abstract][Full Text] [Related]
11. Melatonin facilitates adipose-derived mesenchymal stem cells to repair the murine infarcted heart via the SIRT1 signaling pathway.
Han D; Huang W; Li X; Gao L; Su T; Li X; Ma S; Liu T; Li C; Chen J; Gao E; Cao F
J Pineal Res; 2016 Mar; 60(2):178-92. PubMed ID: 26607398
[TBL] [Abstract][Full Text] [Related]
12. Paracrine action of mesenchymal stem cells revealed by single cell gene profiling in infarcted murine hearts.
Yao Y; Huang J; Geng Y; Qian H; Wang F; Liu X; Shang M; Nie S; Liu N; Du X; Dong J; Ma C
PLoS One; 2015; 10(6):e0129164. PubMed ID: 26043119
[TBL] [Abstract][Full Text] [Related]
13. Dynamic induction of pro-angiogenic milieu after transplantation of marrow-derived mesenchymal stem cells in experimental myocardial infarction.
Rahbarghazi R; Nassiri SM; Ahmadi SH; Mohammadi E; Rabbani S; Araghi A; Hosseinkhani H
Int J Cardiol; 2014 May; 173(3):453-66. PubMed ID: 24679689
[TBL] [Abstract][Full Text] [Related]
14. Coupling erythropoietin secretion to mesenchymal stromal cells enhances their regenerative properties.
Copland IB; Jolicoeur EM; Gillis MA; Cuerquis J; Eliopoulos N; Annabi B; Calderone A; Tanguay JF; Ducharme A; Galipeau J
Cardiovasc Res; 2008 Aug; 79(3):405-15. PubMed ID: 18397963
[TBL] [Abstract][Full Text] [Related]
15. IGF-1C domain-modified hydrogel enhanced the efficacy of stem cells in the treatment of AMI.
Yao Y; Yang L; Feng LF; Yue ZW; Zhao NH; Li Z; He ZX
Stem Cell Res Ther; 2020 Mar; 11(1):136. PubMed ID: 32216819
[TBL] [Abstract][Full Text] [Related]
16. Iron oxide nanoparticle-mediated development of cellular gap junction crosstalk to improve mesenchymal stem cells' therapeutic efficacy for myocardial infarction.
Han J; Kim B; Shin JY; Ryu S; Noh M; Woo J; Park JS; Lee Y; Lee N; Hyeon T; Choi D; Kim BS
ACS Nano; 2015 Mar; 9(3):2805-19. PubMed ID: 25688594
[TBL] [Abstract][Full Text] [Related]
17. Mesenchymal stem cells modified with miR-126 release angiogenic factors and activate Notch ligand Delta-like-4, enhancing ischemic angiogenesis and cell survival.
Huang F; Zhu X; Hu XQ; Fang ZF; Tang L; Lu XL; Zhou SH
Int J Mol Med; 2013 Feb; 31(2):484-92. PubMed ID: 23229021
[TBL] [Abstract][Full Text] [Related]
18. Preconditioning enhances cell survival and differentiation of stem cells during transplantation in infarcted myocardium.
Pasha Z; Wang Y; Sheikh R; Zhang D; Zhao T; Ashraf M
Cardiovasc Res; 2008 Jan; 77(1):134-42. PubMed ID: 18006467
[TBL] [Abstract][Full Text] [Related]
19. AKT-modified autologous intracoronary mesenchymal stem cells prevent remodeling and repair in swine infarcted myocardium.
Yu YS; Shen ZY; Ye WX; Huang HY; Hua F; Chen YH; Chen K; Lao WJ; Tao L
Chin Med J (Engl); 2010 Jul; 123(13):1702-8. PubMed ID: 20819633
[TBL] [Abstract][Full Text] [Related]
20. Autophagy mediates the beneficial effect of hypoxic preconditioning on bone marrow mesenchymal stem cells for the therapy of myocardial infarction.
Zhang Z; Yang C; Shen M; Yang M; Jin Z; Ding L; Jiang W; Yang J; Chen H; Cao F; Hu T
Stem Cell Res Ther; 2017 Apr; 8(1):89. PubMed ID: 28420436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]